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Abstract 
Background: Treatment preferences of patients suffering from depression may affect 
adherence and clinical outcomes. This study examines associations between patients’ 
treatment preferences, their characteristics and illness representations of depression. 
Methods: Illness representations of depression (IPQ-R), treatment acceptability and 
preferences were assessed in 88 newly diagnosed patients with first episode depression. 
Other measures recorded: gender, age, education level, income, psychiatric comorbidity, 
depressive symptomatology (PHQ-9), a family history of depression, and current 
treatment of depression. Multiple logistic regression was used to identify factors 
associated with a preference for psychotherapy. 
Results: Psychotherapy was preferred by 41% of participants, while 31% favored 
antidepressants. Acceptability was strongly associated with preference. Patients 
preferring psychotherapy perceived that their depression has more serious consequences 
than those preferring medication and were more likely to attribute their depression to 
social causes than psychological or physical causes. Participants who preferred 
psychotherapy were more likely to be female, have a university degree and have a family 
history of depression. 
Limitations: The cross-sectional design precludes causal interpretations. 
Conclusions: Preferences vary according to gender, level of education, family history and 
illness representations. It may be important to provide accurate information on both 
treatments and discuss patients’ preferences before prescribing treatment. 
Keywords: Depression; Preferences; Antidepressants; Psychotherapy; Illness 
Representations 
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1. Introduction
In Canada, over one out of ten people (12%) will suffer from depression at one 
point in their lives (Patten et al., 2006). This mental disorder is characterized by a strong 
recurrence rate. During the first year following recovery, between 21% and 37% of 
patients experience a second episode of depression and this rate can reach 85% after 15 
years (Hardeveld et al., 2010). Psychotherapy and antidepressants are the two main 
treatments for depression (CANMAT, 2009). In order to avoid relapses, people suffering 
from depression must properly adhere to their prescribed treatment. In the case of 
antidepressants, the recommended minimum duration of treatment is 6 to 12 months, yet 
30% of patients stop taking their medication in the first 30 days and over 40% stop in the 
first three months (Olfson et al., 2006). As for psychotherapy, according to Canadian 
recommendations a minimum of 12 visits are needed, but only 60% of patients having 
begun psychotherapy receive this much treatment (Duhoux et al., 2012) 
Under current guidelines, health professionals and, in particular, physicians need 
to take patient preferences into account in order to encourage adherence and effective 
treatment of depression (Trivedi et al., 2007; APA, 2000; NICE, 2009). Patients 
obtaining their preferred treatment (whether psychotherapy or pharmacotherapy) is 
associated with the best clinical results, particularly in terms of better remission rates but 
also in terms of a more significant reduction in depressive symptomatology (Clever et al., 
2006; Gelhorn et al., 2011; Kocsis et al., 2009; Loh et al., 2007; Lin et al., 2005; Mergl et 
al., 2011). Persons suffering from depression often have very clear preferences (Churchill 
et al., 2000; Dwight-Johnson et al., 2000) and want to play an active role in treatment 
selection (Stacey et al., 2008; Arora and McHorney, 2000). While physicians generally 
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prefer antidepressants, patients often prefer psychotherapy (Van Schaik et al., 2004; 
Löwe et al., 28; Khalsa et al., 2011; Churchill et al., 2000; Dwight-Johnson et al., 2000; 
Iacoviello et al., 2007; Mergl et al., 2011).  
The rare studies that have examined the predictors of preferences in treatment of 
depression indicate that women are more likely than men to prefer psychotherapy 
(Churchill et al., 2000; Dwight-Johnson et al., 2000; Garcia et al., 2011; Givens et al., 
2007; Khalsa et al., 2011), but few studies have examined the influence of education and 
income level (Morey et al., 2007). People who prefer antidepressants to psychotherapy 
tend to subscribe more to biomedical explanations of illness (Khalsa et al., 2011; Garcia 
et al., 2011), but representations concerning the illness’s chronic nature, seriousness and 
consequences have not been associated with treatment preferences. Prior studies dealt 
with samples that were very heterogeneous in terms of treatment history. We know 
nothing of the preferences of individuals with a newly diagnosed first episode of 
depression when they are offered treatment for the first time. Primary care physicians 
rarely consider the treatment preferences of their depressed patients (Young et al., 2008). 
Better knowledge of the factors associated with the preferences expressed by patients 
could prove useful to physicians. It could help them tailor their discussions with patients 
to treatment preferences and provide appropriate information that supports shared 
decision making.  
 
This study examines treatment preferences among individuals treated in primary 
care for a first episode of a major depression. It has two objectives: (1) to describe 
perceptions of psychotherapy and antidepressants among individuals with a newly 
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diagnosed first episode of depression; (2) to identify the main correlates of treatment 
preferences, including patient characteristics (sex, age, level of education, income and 
psychiatric comorbidity), illness representations and perceived social stigma. 
2. Methods
2.1. Sample 
The participants were recruited in three regions of Quebec, Canada (the Montreal, 
Outaouais and Capitale nationale regions) through advertisements in newspapers, posters 
in medical clinics and pharmacies, and information pamphlets distributed by primary care 
physicians and mental health caregivers. The study’s inclusion criteria were: (1) being 18 
years of age or older; (2) being English or French-speaking; (3) having a first episode 
depression as diagnosed by a physician in the previous eight weeks; (4) having received a 
medical prescription for an antidepressant or psychotherapy; (5) having a PHQ-9 result 
(Spitzer et al., 1999) equal to or greater than 10 on entry into the study. Individuals with 
psychotic disorders and women who were pregnant or who had given birth in the 
previous six months were excluded. A total of 480 persons contacted the research 
coordinator to participate to the study, 337 were excluded for not meeting our inclusion 
criteria, and 55 refused to participate after being informed of the participation expected 
from them. Participants were recruited from September 2010 to April 2012. A financial 
compensation of $20 was offered for completing the questionnaire. A total of 88 persons 
participated in the study (61% participation rate). All patients gave informed written 
consent and the study was approved by the Ethics Board of the Research Centre of the 
University of Montreal Hospital Centre (CRCHUM). 
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2.2. Measures 
2.2.1. Treatment acceptability and preferences 
We adapted the Treatment Acceptability and Preferences Measure (Sidani et al., 
2009) – a generic measure that assesses the acceptability of different treatments – to 
depression. Participants were provided with information on psychotherapy and 
antidepressant treatment in clearly labeled sections: treatment name, description, benefits, 
and disadvantages. Perceptions of treatment acceptability were measured using specific 
attributes: (a) effectiveness in treating depression; (b) appropriateness, i.e. the treatment 
seems to be a logical way to address depression; (c) suitability to the individual’s life 
style; (d) ease of adherence; and (e) convenience, i.e. willingness to apply and adhere to 
the treatment. A total score was calculated for each treatment by averaging the scores on 
all the questions. Final scores could vary from 1 to 5, with higher scores indicating higher 
acceptability. The two scales (psychotherapy and antidepressants) demonstrated good 
internal consistency (Cronbach’s alphas: .77 and .91, respectively). For treatment with 
antidepressants, a supplementary question examined perceptions of the severity of side 
effects. Preference was measured by asking “Do you prefer one of these two types of 
treatment?” The respondent could answer yes or no. If the answer was yes, the 
respondent needed to specify whether he or she preferred antidepressants or 
psychotherapy. 
 
2.2.2. Illness representations  
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The Illness Perceptions Questionnaire-Revised (IPQ-R; Moss-Morris et al., 2002) 
was used to assess cognitive and emotional representations of depression. We replaced 
the word “illness” with “depression” throughout the questionnaire, following a 
recommendation by Moss-Morris et al. (2002). The first part of the IPQ-R, which asks 
participants to rate a number of symptoms perceived as part of the illness, was not 
administered. Seven subscales from the second part were used: acute/chronic timeline, 
depression will last a long time (6 items); cyclical timeline, symptoms come and go in an 
unpredictable way (4 items); consequences, depression will have serious consequences in 
various aspects of life (6 items); personal control, power to control depression is in the 
hands of the depressed person (6 items); treatment control, medical treatment is effective 
in controlling depression (5 items); illness coherence, depression is understandable (5 
items); and emotional representations, depression affects emotions negatively (6 items). 
The internal consistencies of the subscales were satisfactory (Cronbach’s alphas: .51-.84). 
The third part of the IPQ-R assesses causal attributions with 27 items. As recommended 
by Moss-Morris et al. (2002), we performed a factor analysis in order to identify groups 
of causal belief. Three subscales with 18 items were created: psychological attributions, 
such as my personality or my attitude (7 items); physical attributions, like hereditary or 
medical illness (6 items); and social attributions, such as family problems or the loss of a 
significant relationship (5 items). The subscales proved sufficiently reliable (Cronbach’s 
alphas: .62-.75).  
 
 
2.2.3. Patient characteristics 
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Data were collected on sex, age, ethnicity, level of education, employment status 
and family income. Family income was compared to the number of persons in the 
household in order to determine if each participant was above or below the poverty line 
for his or her area. Psychiatric comorbidity was examined for anxiety disorder (with one 
item of the Functional Comorbidity Index; Groll et al., 2005) and for substance abuse or 
dependence disorder (with the MINI; Lecrubier et al., 1998). Participants were asked if 
they were taking an antidepressant at the time of the interview and if they were currently 
in psychotherapy. Current or past depression in the family was also investigated. 
 
2.3. Statistical analysis 
As stated in section 2.2.2, a factor analysis was performed on data from the third 
part of the IPQ-R. The Kaiser-Meyer-Olkin measure of sampling adequacy was used to 
assess the proportion of variance among the variables that might be common variance. A 
value of 0.64 was obtained. The result from Bartlett’s test of sphericity (that the 
correlation matrix is an identity matrix) was highly significant (p<0.00001). Principal 
axis factoring was used as the extraction method. The three retained subscales accounted 
for 40% of the total variance. An orthogonal rotation was performed using the varimax 
approach. 
           Groups preferring psychotherapy or antidepressants were compared using chi-
square tests for categorical variables and Student t-tests for quantitative variables. 
Whenever necessary, Satterhwaite’s correction was used to take into account the 
heteroscedasticity of variances. All the tests were two-sided and the significance level 
was set at 0.05. Because of the multicollinearity among the variables studied, results from 
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these univariate analyses must be interpreted with care. With sample sizes of 27 and 36, a 
two-group X² test will have an 80% power to detect an odds ratio of 4.5, and a two-group 
t-test will have an 80% power to detect a standardized effect size of 0.725 when using a 
0.05 two-sided significance level. 
            A multivariate approach was used to identify factors associated with treatment 
preferences, based on a multiple logistic regression. A backward stepwise procedure was 
applied to identify a set of predictors with an inclusion significance level of 0.050 and an 
exclusion significance level of 0.051. The goodness of fit of the final model was 
evaluated with the Hosmer and Lemeshow statistic. Diagnostic statistics such as 
leverages, studentized deleted residuals and Cook’s distances were obtained to identify 
subjects who may have unduly influenced the model. Besides the well-known approach 
for a normally distributed factor (Hsieh, 1989), to our knowledge no approach has been 
developed to determine sample size and/or power for a multiple logistic regression 
containing only dichotomous variables. All statistical analyses were performed using 
SPSS 20, SPSS Inc., Chicago, USA. 
 
3. Results 
3.1. Sample characteristics 
The sample included 47 men and 41 women with an average age of 42 (SD = 
12.2). Nearly 55% of participants did not have a university degree, and 40% were below 
the poverty line. The PHQ-9 mean score of 15.9 (SD = 5.3) indicates a depression of 
moderate severity, for which both antidepressant and psychotherapy are recommended. 
Almost all (91%) of the participants were taking antidepressants, while only 31% 
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preferred this kind of treatment. More detailed information on participant’s 
characteristics can be found in Table 1.  
 
Insert Table 1 here 
 
3.2. Treatment acceptability 
As show in Table 2, there are many similarities in the participants’ evaluations of 
the acceptability of treatment with psychotherapy and antidepressants. The only 
difference concerns the ease with which all the requirements of the treatment can be met; 
adherence to antidepressants is evaluated as easier than adherence to psychotherapy. 
However, participants evaluated the side effects of antidepressants as “very severe.”  
 
Insert Table 2 here 
 
3.3. Factors associated with treatment preferences 
Univariate analyses were performed on the 63 participants who reported a 
preference for one treatment in order to identify the factors associated with treatment 
preference (see Table 3). The Chi-square tests indicated that women, participants with a 
university degree and participants with a family history of depression are more likely to 
prefer psychotherapy. Participants preferring psychotherapy were less likely to have 
received such treatment. With regard to illness representations, the t-test revealed that 
participants who preferred psychotherapy feel that depression has more serious 
consequences on their lives. Patients who preferred psychotherapy more strongly 
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endorsed social attributions for their depression than patients who preferred 
antidepressants. Treatment acceptability is associated with preference: participants who 
preferred psychotherapy evaluated its acceptability more favorably. The same was true of 
the participants who preferred antidepressants.   
 
Insert Table 3 here 
 
The logistic regression reported in Table 4 indicates that, in addition to current 
exposure to psychotherapy, female gender, university level of education and family 
history of depression remain significant correlates of a preference for psychotherapy. 
Treatment acceptability was not included in the regression model because of its high 
correlation with preference (r = .68), which creates a problem of collinearity. Table 5 
presents probabilities of preferring psychotherapy as estimated from the multiple logistic 
regression model when controlling for current treatment. For example, if we compare 
lowest and highest probabilities, we see that the probability that men without a family 
history of depression and no university degree will prefer psychotherapy is only 10.8%. 
In contrast, the probability that a woman with a family history of depression and a 
university degree will prefer psychotherapy is 98.6%.  
 
Insert Table 4 and Table 5 here 
 
4. Discussion 
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This is the first study to have examined the treatment preferences of persons with 
newly diagnosed first episode depression. Another unique contribution of this study lies 
in the fact that it relates treatment preferences to various characteristics of the participants 
and their representations of the illness. Our results suggest that most persons with newly 
diagnosed first episode depression prefer one of the two recognized treatments over the 
other. This preference is influenced by several factors, including the person’s gender, 
level of education, and family history. It is also strongly influenced by the patient’s 
personal evaluation of certain characteristics of the treatment, i.e. its effectiveness, 
appropriateness, suitability, ease of adherence and convenience. 
Psychotherapy is the preferred mode of treatment among individuals with a newly 
diagnosed first episode of depression, despite the fact that it is considered more 
demanding than antidepressants. Our study therefore confirms prior observations in 
samples of persons who were not clinically depressed or not formally diagnosed (Van 
Schaik et al., 2004; Löwe et al., 28; Khalsa et al., 2011; Churchill et al., 2000; Dwight-
Johnson et al., 2000; Iacoviello et al., 2007; Mergl et al., 2011). Antidepressants are 
perceived by persons in a first episode of depression as having serious side effects, and 
this perception may help make antidepressants less preferred as a treatment. Physicians 
do not provide their patients with much information when they prescribe antidepressants 
(Young et al., 2006). However, many patients could be reassured if they received 
education on the side effects of antidepressants, combined with an opportunity to modify 
the treatment if it proves too toxic. This approach could change their preferences. When 
physicians provide information to their patients on antidepressant treatment (minimum 
required duration, expected side effects, the need to continue treatment even if they start 
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to feel better), patients are better informed and more likely to demonstrate better 
adherence to treatment (Brown et al., 2007; Bull et al., 2002; Bultman and Svarstad, 
2000; Lin et al., 1995). 
Our results also suggest that individuals who prefer psychotherapy are at a 
disadvantage compared to those who prefer antidepressants. Only 50% of the participants 
who preferred psychotherapy received it, compared to 96% of the persons who preferred 
medication. Many factors may help explain this situation. First, it is more difficult to gain 
access to psychotherapy than it is to antidepressants, which are available at a modest cost 
in all pharmacies. Significant barriers can adversely affect the accessibility of 
psychotherapy, including its cost, time constraints, lack of knowledge about how to go 
about consulting with a recognized psychotherapist, the difficulty finding such a resource 
person nearby, waiting lists for consultations, etc. (Mohr et al., 2006; Mohr et al., 2010). 
It is also possible that physicians do not recommend psychotherapy to patients suffering 
from depression or do not refer them to professionals deemed able to provide 
psychotherapy, such as psychologists or social workers (Piek et al., 2011; Richards et al., 
2004; Wang et al., 2003). But psychotherapy is effective in primary care, particularly 
when patients are referred by their family physicians (Cuijpers et al., 2009). 
Neighbourhood medical clinics rarely have psychologists on-site, easily accessible to 
patients. Physicians would undoubtedly be more inclined to refer their patients to 
psychologists if they are regularly in contact with psychologists, such as by working in 
the same clinic (Craven and Bland, 2006).  
Our results indicate that three out of four women prefer psychotherapy to 
antidepressants, while men are more evenly split between the two types of treatment. 
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Previous studies have shown that being female is positively associated with a preference 
for psychotherapy (Churchill et al., 2000; Dwight-Johnson et al., 2000). Since women are 
more likely to talk about their emotions and distress (Komiya et al., 2000; O’Loughlin et 
al., 2011), it is possible that the ease with which they express feelings may explain part of 
this preference. However, even though men’s reticence to ask for professional 
psychological assistance when they are experiencing emotional distress has been well 
documented (Berger et al., 2005; MacKenzie et al., 2006; Mojtabai et al., 2006; Oliffe et 
al., 2012; Johnson et al., 2012; Pedersen and Vogel, 2007), it is surprising to observe that 
close to half of the men in our sample (43%) preferred psychotherapy. Our results 
therefore qualify the literature on men’s lack of interest in psychotherapy. It is important 
that physicians, when making diagnoses of depression, take the time to confirm with their 
male patients whether they have a preference for psychotherapy and, if they do, to 
propose resources that could help them gain access to this type of treatment. Physicians 
are less likely to refer men to psychotherapy than they are to refer women (Alvidrez and 
Arean, 2002). 
Our study has revealed an association between level of education and treatment 
preference. Individuals with a university degree are more likely to prefer psychotherapy 
than those with less education. There are several potential explanations for this finding. 
Psychotherapy requires talking about your suffering, emotions and problems. Patients 
must be able to express themselves well, and be ready to spend a considerable amount of 
time and energy treating their depression. These two characteristics may be more often 
found in people with more formal education. Furthermore, a university degree usually 
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leads to a higher salary, which removes or at least considerably reduces the financial 
obstacle to receiving psychotherapy. 
According to our study’s results, someone with a family member who has already 
suffered from depression is more likely to prefer psychotherapy. It is possible that such 
individuals consider talking about their depression less of a taboo; family experience may 
have reduced the stigma surrounding the illness (Wang and Lai, 2008). They may also 
attribute their depression to events in their childhood that they would like to explore in 
psychotherapy.  
 Representations of depression are also associated with treatment preferences. Our 
results indicate that persons who prefer psychotherapy believe that their depression has 
more serious consequences on their lives than those who prefer antidepressants. These 
individuals are more inclined to attribute their depression to social causes, such as 
marital, family or interpersonal problems. These representations may make a patient 
more motivated to undertake psychotherapy and to invest the time, money and energy 
required to learn different strategies for solving problems in their personal relationships 
and mitigate the negative impacts of their depression. Antidepressants act on depressive 
symptomatology but not on the individual’s ability to maintain harmonious relationships. 
Knowledge of patients’ representations of illness may help physicians recommend 
treatment that their patients will find more appropriate and will not abandon prematurely. 
Shared decision making needs to be encouraged, due to its positive impact on adherence 
to treatment and clinical results (Kocsis et al., 2009; Clever et al., 2006; Loh et al., 2007; 
Lin et al., 2005; Mergl et al., 2011). 
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Our study has some limitations. First, the cross-sectional design prevents us from 
making causal interpretations. Our sample was small, and the percentage of participants 
with a university degree was higher than that found in population-based surveys on 
persons suffering from depression. This suggests that caution should be exercised in 
interpreting the results. Future studies of larger samples are required in order to confirm 
the associations we have found between gender, level of education, a family history of 
depression and representations of the illness. 
This study has many implications for practice. First, once physicians have arrived 
at a diagnosis of depression, they should take the time to inform the patient of the two 
potential forms of treatment and ask which they prefer. Asking questions on 
representations of the illness and whether there is a family history of depression may help 
the physician identify, with the patient, the most appropriate treatment. The physician 
could also correct any misconceptions about antidepressants, such as their side effects, 
which are perceived to be very serious. Since psychotherapy is the treatment most often 
preferred by persons suffering from depression, physicians should make every effort to 
discuss this treatment option with patients presenting mild to moderate symptoms. 
Mechanisms should also be in place for making referrals to psychotherapy.  
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Table 1. Description of participants (n = 88)  
Characteristics  n (%) 
Gender   
Men 47 (53.4) 
Women 41 (46.6) 
Age    
18 to 24 years 9 (10.2) 
25 to 35 years 18 (20.5) 
36 to 45 years  21 (23.9) 
46 to 59 years 32 (36.4) 
60 years or older 8 (9.1) 
Educational level   
< University 48 (54.5) 
University 40 (45.5) 
Employment status   
Employed (full time, part time or on sick leave) 58 (65.9) 
Unemployed 30 (34.1) 
Income
a
    
Above poverty line 52 (59.8) 
Below poverty line 35 (40.2) 
Ethnic background   
Canadian 68 (77.3) 
Other 20 (22.7) 
Family history of depression
b
    
Yes 55 (64.7) 
No 30 (35.3) 
Psychiatric comorbidity    
Yes 61 (69.3) 
No 27 (30.7) 
Current treatment    
Antidepressants only 50 (56.8) 
Psychotherapy only 2 (2.3) 
Both treatments 30 (34.1) 
None 6 (6.8) 
Treatment preferences   
Antidepressants 27 (30.7) 
Psychotherapy 36 (40.9) 
None 25 (28.4) 
a
n=87 ; 
b
n=85 
 
 
Table 1
Table 2. Treatment acceptability of antidepressants and psychotherapy 
Characteristics (n=88) Antidepressants Psychotherapy p value 
 M (SD) M (SD)  
Effectiveness 2.9 (1.0) 3.1 (1.2) .259 
Appropriateness 3.4 (1.0) 3.5 (1.1) .446 
Suitability 3.2 (0.9) 3.2 (1.3) .941 
Severity of side effects 3.8 (1.0) -  
Ease of adherence 3.3 (1.1) 2.8 (1.2) .002 
Convenience 3.7 (1.1) 3.5 (1.3) .237 
Total 3.4 (0.6) 3.2 (1.0) .227 
 
Table 2
Table 3. Factors associated with treatment preferences 
Variables (n = 63) 
Preference for 
antidepressants 
 (n = 27) 
Preference for 
psychotherapy  
(n = 36) 
p value 
 n (%) n (%)  
Gender       
Women 7 (25.0) 21 (75.0) .010 
Men 20 (57.1) 15 (42.9)  
Educational level       
< University 20 (55.6) 16 (44.4) .019 
University 7 (25.9) 20 (74.1)  
Employment status      
Employed 14 (36.8) 24 (63.2) .234 
Unemployed 13 (52.0) 12 (48.0)  
Income
a
       
Below poverty line  10 (37.0) 17 (63.0) .364 
Above poverty line 17 (48.6) 18 (51.4)  
Ethnic background      
Canadian 23 (47.9) 25 (52.1) .147 
Other 4 (26.7) 11 (73.3)  
Family member with depression (current or past)
b
    
    Yes 13 (34.2) 25 (65.8) .042 
     No 14 (60.9) 9 (39.1)  
Psychiatric comorbidity    
    Yes 19 (43.2) 25 (56.8) .937 
    No 8 (42.1) 11 (57.9)  
Current preferred treatment    
Yes 26 (59.1) 18 (40.9) .000 
No 1 (5.3) 18 (94.7)  
Current antidepressant treatment       
Yes 26 (46.4) 30 (53.6) .105 
No 1 (14.3) 6 (85.7)  
Current psychotherapy       
Yes 3 (14.3) 18 (85.7) .001 
No 24 (57.1) 18 (42.9)  
 M (SD) M (SD)  
Age (years) 45.6 (12.8) 41.2 (12.3) .176 
Depression severity (PHQ-9) 14.8 (5.2) 16.7 (5.5) .180 
Illness representations      
Timeline: acute/chronic  2.7 (1.0) 2.7 (0.6) .725 
Table 3
a
n = 62 ; 
b
n = 61  
 
  
Table 3. Factors associated with treatment preferences (continued) 
    
 
Variables 
Preference for 
antidepressants 
(n = 27) 
Preference for 
psychotherapy 
(n = 36)  
p value 
 M (SD) M (SD)  
 Consequences 3.5 (0.7) 3.9 (0.6) .019 
  Personal control 3.8 (0.6) 3.8 (0.7) .971 
  Treatment control 3.9 (0.7) 3.8 (0.7) .537 
  Illness coherence 3.5 (0.9) 3.6 (1.0) .456 
  Timeline: cyclical 2.9 (0.9) 3.4 (1.0) .077 
 Emotional representations 3.6 (0.8) 3.9 (0.6) .193 
Depression attributions    
Physical 2.1 (0.7) 2.0 (0.9) .594 
Psychological 3.4 (0.7) 3.6 (0.9) .382 
Social 2.6 (0.9) 3.1 (0.9) .049 
Treatment acceptability    
 Antidepressants 3.6 (0.6) 3.1 (0.7) .006 
 Psychotherapy  2.3 (0.7) 3.8 (0.8) .000 
Table 4. Predictors of psychotherapy preference among 61 participants newly diagnosed with 
depression, by multiple logistic regression analysis 
Covariate  B S.E. Wald df p OR 95% CI 
Female  2.28 0.83 7.57 1 .006 9.8 1.9-50.0 
University educational level 2.03 0.78 6.73 1 .009 7.6 1.6-35.4 
Family history of depression 2.06 0.80 6.57 1 .010 7.8 1.6-37.7 
Current psychotherapy 2.85 0.94 9.20 1 .002 17.3 2.7-109.3 
 
Table 4
Table 5. Probabilities of preferring psychotherapy as estimated from the multiple logistic 
regression model when controlling for current treatment 
 
 Education 
< University University 
Family history Family history 
 
 
Gender 
 No Yes No Yes 
Female 0.543 0.903 0.900 0.986 
Male 0.108 0.486 0.480 0.878 
 
Table 5
Role of funding source 
This research was funded by the Canadian Institutes of Health Research (CIHR). 
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